Structure-activity relationships (SAR) of [D-Arg(2)]dermorphin(1-4) analogues, N(alpha)-amidino-Tyr-D-Arg-Phe-X.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Chemical and pharmaceutical bulletin

• Publication date

  2002-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1248/CPB.50.771PMID 12045331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The dermorphin peptide family.

  1996cited by this paper
• Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment.

  1994cited by this paper
• Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes.

  1993cited by this paper
• Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.

  1993cited by this paper
• mu opiate receptor: cDNA cloning and expression.

  1993cited by this paper
• Primary structures and expression from cDNAs of rat opioid receptor δ‐and μ‐subtypes

  1993cited by this paper
• Cloning of a delta opioid receptor by functional expression.

  1992cited by this paper
• Antinociceptive mechanisms of [D-Arg2]-dermorphin tripeptide analogs.

  1992cited by this paper
• The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.

  1992cited by this paper
• A one-pot N-protection of L-arginine.

  1991cited by this paper
• Development of receptor-specific opioid peptide analogues.

  1991cited by this paper
• Studies on analgesic oligopeptides. VI. Further studies of synthesis and biological properties of tripeptide alkylamides, Tyr-D-Arg-Phe-X.

  1990cited by this paper
• N-terminal tetrapeptide of dermorphin and D-Arg-substituted tetrapeptides: inactivation process of the antinociceptive activity by peptidase.

  1990cited by this paper
• Recent developments in the design of receptor specific opioid peptides

  1989cited by this paper
• Antinociception and physical dependence produced by [D‐Arg2] dermorphin tetrapeptide analogues and morphine in rats

  1988cited by this paper
• Comparison of the antinociceptive effects of new [D-Arg2]-dermorphin tetrapeptide analogs and morphine in mice.

  1988cited by this paper
• Studies on analgesic oligopeptides. V. Structure--activity relationship of tripeptide alkylamides, Tyr-D-Arg-Phe-X.

  1988cited by this paper
• Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.

  1987cited by this paper
• Opioid activities of D-Arg2-substituted tetrapeptides.

  1987cited by this paper
• Dermorphin analogues containing D‐kyotorphin: structure‐antinociceptive relationships in mice

  1986cited by this paper
• Studies on analgesic oligopeptides. IV. Synthesis and analgesic activity of N-terminal shorter analogs of [D-Arg2]dermorphin and des-Tyr1-dermorphin analogs.

  1985cited by this paper
• Studies on analgesic oligopeptides. III. Synthesis and analgesic activity after subcutaneous administration of [D-Arg2]dermorphin and its N-terminal tetrapeptide analogs.

  1985cited by this paper
• The analgesic activity of D-Arg2-dermorphin and its N-terminal tetrapeptide analogs after subcutaneous administration in mice.

  1985cited by this paper
• Structure-activity relationships of dermorphin synthetic analogues.

  1985cited by this paper
• D-Arg2-dermorphin tetrapeptide analogs: a potent and long-lasting analgesic activity after subcutaneous administration.

  1984cited by this paper
• IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983.

  1984cited by this paper
• Antinociceptive activities of synthetic dipeptides in mice

  1982cited by this paper
• Neurotensin and substance P: differential effects on plasma cholesterol levels in conscious ovariectomized rats.

  1981cited by this paper
• Synthetic peptides related to the dermorphins. I. Synthesis and biological activities of the shorter homologues and of analogues of the heptapeptides.

  1981cited by this paper
• Conformationsl aspects of polypeptide structure. XLV. Nuclear magnetic resonance study of trans-cis isomerization in an N-methyl-L-alanine derivative.

  1974cited by this paper
• Chemistry and biochemistry.

  1973cited by this paper
• NMR studies on the conformation of derivatives of the side chain of oxytocin: examples of cis-trans isomerism.

  1971cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Development of Multifunctional and Orally Active Cyclic Peptide Agonists of Opioid/Neuropeptide FF Receptors that Produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side Effects.

  2021cites this paper
• Amino sulfonic acids, peptidosulfonamides and other related compounds

  2018cites this paper
• N‐terminal guanidinylation of the cyclic 1,4‐ureido‐deltorphin analogues: the synthesis, receptor binding studies, and resistance to proteolytic digestion

  2015cites this paper
• Synthesis and biological evaluation of an orally active glycosylated endomorphin-1.

  2012cites this paper
• Lack of a rewarding effect and a locomotor-enhancing effect of the selective μ-opioid receptor agonist amidino-TAPA

  2010cites this paper
• N-methyl-N-nosyl-beta(3)-amino acids.

  2007cites this paper
• N- and Calpha-methylation in biologically active peptides: synthesis, structural and functional aspects.

  2004cites this paper
• Synthesis and antinociceptive activity of orally active opioid peptides: improvement of oral bioavailability by esterification.

  2003cites this paper